5Lesprit P, Godeau B, Bertrand G, et al. Pulmonary hyper- tension in POEMS syndrome: a new feature mediated by cy- tokines [J ]. Am J Respir Crit Care Med, 1998,157 : 907 - 911.
6Niimi H, Arimura K, Jonosono M, et al. VEGF Is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome [J]. Internal Med, 2000,39:1101 - 1104.
7Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syn- drome: definitions and long-term outcome[ J ]. Blood, 2003, 101 : 2496 -2506.
8Allam JS, Kennedy CC, Aksamit TR, et al. Pulmonary man- ifestations in patients with POEMS syndrome [ J ]. Chest, 2008, 133:969-974.
9Jouve P, Humbert M, Chauveheida MP, et al. POEMS syn- drome-related pulmonary hypertension is steroid-responsive [J]. Respir Med, 2007, 101:353 -355.
10Mukerjee D, Kingdon E, Vanderpump M, et al. Pathophysi- ological insights from a case of reversible pulmonary arterial hypertension [J]. J R Soc Med, 2003,96:403 -404.
